查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1751136

2025年全球肌腱炎市場報告

Tendinopathy Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年肌腱炎市場規模將強勁成長。到2029年，該市場規模將達到163.5億美元，年複合成長率（CAGR）為5.3%。預測期內的成長歸因於多種因素，例如體育和健身活動參與度的提高、老年人口的成長、對早期肌腱損傷管理意識的增強、微創手術的普及、醫療保健基礎設施的擴展以及用於肌肉骨骼監測的穿戴式設備的普及。預計在此期間的主要趨勢包括再生療法的應用、肌腱修復生技藥品的開發、微創手術技術的進步、用於康復監測的穿戴式設備的創新、疼痛管理配方的改進以及人工智慧驅動的診斷工具的整合。

運動傷害發生率的上升預計將推動肌腱炎市場的擴張。運動傷害是指在體育運動和運動過程中遭受的身體損傷，從輕微的扭傷和拉傷到嚴重的骨折和脫臼。運動傷害的增加與訓練強度的增加和年輕運動員參加比賽有關，這給尚未完全發育成熟的肌肉和關節帶來了過度的壓力。此類損傷會使肌腱承受反覆的壓力和突然的超負荷，從而導致肌腱炎，並隨著時間的推移造成微斷裂、發炎和退化。例如，英國保險經紀公司豪頓集團控股有限公司於2023年11月報告稱，2022年10月至2023年1月期間，英超聯賽中腳踝受傷的嚴重程度增加了170%，2022年卡達世界盃後，小腿/脛骨受傷增加了200%，腿筋受傷增加了130%。因此，運動傷害發生率的上升正在促進肌腱炎市場的成長。

肌腱炎市場的主要企業正專注於開發先進產品，例如生物誘導植入，以加速癒合、改善肌腱再生並縮短恢復時間。生物誘導植入是一種創新醫療醫療設備，它透過促進類似肌腱的組織生長來刺激人體的自然癒合過程，從而改善肌腱修復的臨床效果。例如，2023 年 7 月，英國醫療科技公司 Smith+Nephew 在印度推出了 REGENETEN 生物誘導植入物。這種基於膠原蛋白的裝置肩迴旋肌修復方面。此植入的主要特點是其微創輸送方式，使骨科醫生能夠在不修改現有手術技術的情況下對肌腱進行生物強化，為肌腱炎患者提供快速、安全、有效的治療選擇。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球肌腱炎 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球腱鞘炎市場：成長率分析
  • 全球腱鞘炎市場表現：規模與成長，2019-2024 年
  • 全球腱鞘炎市場預測：2024-2029 年及 2034 年規模與成長
  • 全球腱鞘炎總目標市場（TAM）

第6章市場區隔

  • 全球腱鞘炎市場類型、表現及預測（2019-2024、2024-2029、2034）
  • 跟腱炎
  • 肩旋板腱炎
  • 肱骨外上髁炎（網球肘）
  • 膝腱
  • 其他類型
  • 全球腱鞘炎市場（按治療類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 治療
  • 藥品
  • 手術治療
  • 再生醫學
  • 全球腱鞘炎市場（依給藥途徑、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 口服
  • 局部的
  • 注射
  • 全球腱鞘炎市場（依最終用戶、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診所
  • 門診手術中心
  • 復健中心
  • 全球肌腱炎市場，依阿基里斯腱炎類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 跟腱插入性腱炎
  • 非插入性跟腱炎
  • 全球肌腱炎市場，肩旋板肌腱炎細分，按類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 岡上肌腱炎
  • 岡下肌腱炎
  • 肩胛下肌腱炎
  • 小圓肌腱炎
  • 全球腱鞘炎市場、肱骨外上髁炎（網球肘）分類（依類型）、績效及預測，2019-2024、2024-2029、2034
  • 肌腱過度使用損傷
  • 肌腱退化性損傷
  • 全球肌腱炎市場，依膝腱腱炎類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 近端膝蓋骨腱炎
  • 遠端膝蓋骨腱炎
  • 全球腱鞘炎市場，按類型、績效和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 德奎文氏腱鞘炎
  • 腓骨肌腱炎
  • 屈肌腱炎
  • 伸肌腱鞘炎

第7章 區域和國家分析

  • 全球腱鞘炎市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球腱鞘炎市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 肌腱炎市場：競爭格局
  • 腱鞘炎市場：公司簡介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Sanofi SA
  • Bristol-Myers Squibb Company
  • Novartis AG
  • GSK plc
  • Medtronic Plc
  • 3M Company
  • Stryker Corporation
  • Teva Pharmaceutical Industries
  • Zimmer Biomet
  • Smith & Nephew plc
  • Coloplast A/S
  • Arthrex
  • Bioventus
  • Tynor Orthotics
  • Almatica Pharma Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029 年腱鞘炎市場：提供新機會的國家
  • 2029 年腱鞘炎市場：細分領域帶來新機會
  • 腱鞘炎市場 2029：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r34990

Tendinopathy is a condition that affects the tendons, leading to pain, swelling, and reduced movement or strength. It is typically caused by repetitive stress or overuse, resulting in the deterioration of tendon tissue rather than acute inflammation.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of tendinopathy include Achilles tendinopathy, rotator cuff tendinopathy, lateral epicondylitis (tennis elbow), patellar tendinopathy, and others. Achilles tendinopathy specifically refers to an injury to the Achilles tendon, which connects the calf muscles to the heel bone. Treatment options for tendinopathy include therapy, medications, surgical interventions, and regenerative medicine approaches. The condition can be managed using various routes of administration, such as oral, topical, and injectable methods. These treatments are provided in various healthcare settings, including hospitals, clinics, and ambulatory surgical centers.

The tendinopathy market research report is one of a series of new reports from The Business Research Company that provides tendinopathy market statistics, including the tendinopathy industry global market size, regional shares, competitors with the tendinopathy market share, detailed tendinopathy market segments, market trends, and opportunities, and any further data you may need to thrive in the tendinopathy industry. This tendinopathy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tendinopathy market size has grown strongly in recent years. It will grow from$12.63 billion in 2024 to $13.32 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth during the historic period can be attributed to several factors, including the rising incidence of sports-related injuries, a growing aging population, increased awareness of musculoskeletal disorders, the expanding availability of physical therapy services, and greater healthcare spending globally.

The tendinopathy market size is expected to see strong growth in the next few years. It will grow to$16.35 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth during the forecast period can be attributed to several factors, including increasing participation in sports and fitness activities, a rising geriatric population, growing awareness of early tendon injury management, the increasing availability of minimally invasive procedures, expanding healthcare infrastructure, and the rising adoption of wearable devices for musculoskeletal monitoring. Major trends expected during this period include the adoption of regenerative therapies, the development of biologics for tendon repair, advancements in minimally invasive surgical techniques, innovations in wearable devices for rehabilitation monitoring, improvements in pain management formulations, and the integration of AI-driven diagnostic tools.

The growing incidence of sports injuries is expected to drive the expansion of the tendinopathy market. Sports injuries refer to physical injuries sustained during athletic activities or exercise, ranging from minor sprains and strains to more severe fractures or dislocations. The rise in sports injuries is linked to increased training intensity and competition at younger ages, which places excessive stress on developing muscles and joints before they are fully matured. These injuries can lead to tendinopathy by subjecting tendons to repetitive stress or sudden overload, causing microscopic tears, inflammation, and degeneration over time. For example, in November 2023, Howden Group Holdings Ltd., a UK-based insurance intermediary company, reported that the severity of ankle injuries in the English Premier League increased by 170% between October 2022 and January 2023, while calf/shin injuries surged by 200% and hamstring injuries rose by 130%, following the FIFA World Cup Qatar 2022. As such, the rising incidence of sports injuries is contributing to the growth of the tendinopathy market.

Leading companies in the tendinopathy market are focusing on developing advanced products, such as bioinductive implants, to accelerate healing, improve tendon regeneration, and reduce recovery time. Bioinductive implants are innovative medical devices that stimulate the body's natural healing process by promoting the growth of tendon-like tissue, leading to improved clinical outcomes in tendon repair. For example, in July 2023, Smith+Nephew, a UK-based medical technology company, launched the REGENETEN Bioinductive Implant in India. This collagen-based device transforms tendon repair by encouraging biological healing through the induction of new tissue growth at the injury site, particularly for rotator cuff repairs. A key feature of the implant is its minimally invasive delivery method, which allows orthopedic surgeons to biologically reinforce the tendon without changing existing surgical techniques, offering a quicker, safer, and more effective treatment option for tendinopathy patients.

In April 2023, Vander-Bend Manufacturing, Inc., a U.S.-based medical technology company, acquired Omni Components Corporation for an undisclosed amount. With this acquisition, Vander-Bend aims to expand its precision manufacturing capabilities, enhance its product offerings in the medical technology sector, and strengthen its position in the market by integrating Omni Components Corporation's expertise in producing complex, high-precision components. Omni Components Corporation is a U.S.-based medical device company specializing in tendon surgeries.

Major players in the tendinopathy market are Pfizer Inc., Johnson and Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Novartis AG, GSK plc, Medtronic Plc, 3M Company, Stryker Corporation, Teva Pharmaceutical Industries, Zimmer Biomet, Smith & Nephew plc, Coloplast A/S, Arthrex, Bioventus, Tynor Orthotics, Almatica Pharma Inc.

North America was the largest region in the tendinopathy market in 2024. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tendinopathy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tendinopathy market consists of revenues earned by entities by providing services such as physical therapy and rehabilitation programs, pain management, arthroscopic debridement, and occupational therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The tendinopathy market also include sales of nonsteroidal anti-inflammatory drugs, creams and gels, and capsaicin creams. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tendinopathy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tendinopathy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tendinopathy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tendinopathy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Achilles Tendinopathy; Rotator Cuff Tendinopathy; Lateral Epicondylitis (Tennis Elbow); Patellar Tendinopathy; Other Types
  • 2) By Treatment Type: Therapy; Medication; Surgical Treatment; Regenerative Medicine
  • 3) By Route Of Administration: Oral; Topical; Injectable
  • 4) By End User: Hospitals; Clinics; Ambulatory Surgical Centers; Rehabilitation Centers
  • Subsegments:
  • 1) By Achilles Tendinopathy: Insertional Achilles Tendinopathy; Non-insertional Achilles Tendinopathy
  • 2) By Rotator Cuff Tendinopathy: Supraspinatus Tendinopathy; Infraspinatus Tendinopathy; Subscapularis Tendinopathy; Teres Minor Tendinopathy
  • 3) By Lateral Epicondylitis (Tennis Elbow): Tendon Overuse Injuries; Tendon Degeneration Injuries
  • 4) By Patellar Tendinopathy: Proximal Patellar Tendinopathy; Distal Patellar Tendinopathy
  • 5) By Other Types: De Quervain's Tenosynovitis; Peroneal Tendinopathy; Flexor Tendinopathy; Extensor Tendinopathy
  • Companies Mentioned: Pfizer Inc.; Johnson and Johnson; Merck & Co. Inc.; AbbVie Inc.; Bayer AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tendinopathy Market Characteristics

3. Tendinopathy Market Trends And Strategies

4. Tendinopathy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Tendinopathy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Tendinopathy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Tendinopathy Market Growth Rate Analysis
  • 5.4. Global Tendinopathy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Tendinopathy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Tendinopathy Total Addressable Market (TAM)

6. Tendinopathy Market Segmentation

  • 6.1. Global Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Achilles Tendinopathy
  • Rotator Cuff Tendinopathy
  • Lateral Epicondylitis (Tennis Elbow)
  • Patellar Tendinopathy
  • Other Types
  • 6.2. Global Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Therapy
  • Medication
  • Surgical Treatment
  • Regenerative Medicine
  • 6.3. Global Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Topical
  • Injectable
  • 6.4. Global Tendinopathy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Rehabilitation Centers
  • 6.5. Global Tendinopathy Market, Sub-Segmentation Of Achilles Tendinopathy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Insertional Achilles Tendinopathy
  • Non-insertional Achilles Tendinopathy
  • 6.6. Global Tendinopathy Market, Sub-Segmentation Of Rotator Cuff Tendinopathy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Supraspinatus Tendinopathy
  • Infraspinatus Tendinopathy
  • Subscapularis Tendinopathy
  • Teres Minor Tendinopathy
  • 6.7. Global Tendinopathy Market, Sub-Segmentation Of Lateral Epicondylitis (Tennis Elbow), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tendon Overuse Injuries
  • Tendon Degeneration Injuries
  • 6.8. Global Tendinopathy Market, Sub-Segmentation Of Patellar Tendinopathy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Proximal Patellar Tendinopathy
  • Distal Patellar Tendinopathy
  • 6.9. Global Tendinopathy Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • De Quervain's Tenosynovitis
  • Peroneal Tendinopathy
  • Flexor Tendinopathy
  • Extensor Tendinopathy

7. Tendinopathy Market Regional And Country Analysis

  • 7.1. Global Tendinopathy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Tendinopathy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tendinopathy Market

  • 8.1. Asia-Pacific Tendinopathy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tendinopathy Market

  • 9.1. China Tendinopathy Market Overview
  • 9.2. China Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tendinopathy Market

  • 10.1. India Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tendinopathy Market

  • 11.1. Japan Tendinopathy Market Overview
  • 11.2. Japan Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tendinopathy Market

  • 12.1. Australia Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tendinopathy Market

  • 13.1. Indonesia Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tendinopathy Market

  • 14.1. South Korea Tendinopathy Market Overview
  • 14.2. South Korea Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tendinopathy Market

  • 15.1. Western Europe Tendinopathy Market Overview
  • 15.2. Western Europe Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tendinopathy Market

  • 16.1. UK Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tendinopathy Market

  • 17.1. Germany Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tendinopathy Market

  • 18.1. France Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tendinopathy Market

  • 19.1. Italy Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tendinopathy Market

  • 20.1. Spain Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tendinopathy Market

  • 21.1. Eastern Europe Tendinopathy Market Overview
  • 21.2. Eastern Europe Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tendinopathy Market

  • 22.1. Russia Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tendinopathy Market

  • 23.1. North America Tendinopathy Market Overview
  • 23.2. North America Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tendinopathy Market

  • 24.1. USA Tendinopathy Market Overview
  • 24.2. USA Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tendinopathy Market

  • 25.1. Canada Tendinopathy Market Overview
  • 25.2. Canada Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tendinopathy Market

  • 26.1. South America Tendinopathy Market Overview
  • 26.2. South America Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tendinopathy Market

  • 27.1. Brazil Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tendinopathy Market

  • 28.1. Middle East Tendinopathy Market Overview
  • 28.2. Middle East Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tendinopathy Market

  • 29.1. Africa Tendinopathy Market Overview
  • 29.2. Africa Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tendinopathy Market Competitive Landscape And Company Profiles

  • 30.1. Tendinopathy Market Competitive Landscape
  • 30.2. Tendinopathy Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Tendinopathy Market Other Major And Innovative Companies

  • 31.1. Sanofi SA
  • 31.2. Bristol-Myers Squibb Company
  • 31.3. Novartis AG
  • 31.4. GSK plc
  • 31.5. Medtronic Plc
  • 31.6. 3M Company
  • 31.7. Stryker Corporation
  • 31.8. Teva Pharmaceutical Industries
  • 31.9. Zimmer Biomet
  • 31.10. Smith & Nephew plc
  • 31.11. Coloplast A/S
  • 31.12. Arthrex
  • 31.13. Bioventus
  • 31.14. Tynor Orthotics
  • 31.15. Almatica Pharma Inc.

32. Global Tendinopathy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tendinopathy Market

34. Recent Developments In The Tendinopathy Market

35. Tendinopathy Market High Potential Countries, Segments and Strategies

  • 35.1 Tendinopathy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Tendinopathy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Tendinopathy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250617_r34990_Tendinopathy_GMR_2025